Protagonist Therapeutics, Inc. (PTGX)

91.54 -3.25 (-3.43%) USD  |  NASDAQ  |  Dec 16, 16:00
91.75 +0.21 (+0.23%) After-Hours: 06:31
More

Protagonist Therapeutics Normalized Basic EPS (Quarterly)

Normalized Basic EPS (Quarterly) Chart

View Normalized Basic EPS (Quarterly) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Normalized Basic EPS (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Normalized Basic EPS (Quarterly) Range, Past 5 Years

View Normalized Basic EPS (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Normalized Basic EPS (Quarterly) Benchmarks

View Normalized Basic EPS (Quarterly) Benchmarks
Start Trial
Johnson & Johnson Upgrade
ADMA Biologics, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade